Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Prostatic Neoplasms 15Leiomyoma 4Myofibroma 2Endometriosis 2Uterine Neoplasms 1Uterine Hemorrhage 1Prostate Adenocarcinoma 1Pregnancy Complications 1Pathologic Complete Response 1Neoplasm, Residual 1Neoplasm Metastasis 1Myoma 1Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1Menorrhagia 1Adenocarcinoma 1

Interventions

relugolix 2Hysterectomy 2carbetocin 1Uterine Myomectomy 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Misoprostol 1Methylergonovine 1Ergonovine 1CA-125 Antigen 1Buthionine Sulfoximine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Myofibroma × relugolix × Clear all
NCT06953076 2025-08-17

MySaturn

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
111 enrolled
Gynecologic

Leiomyoma, Myoma, Uterine Hemorrhage, Uterine Neoplasms, Myofibroma

NCT05862272 2025-08-06

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Sumitomo Pharma Switzerland GmbH

Phase 3 Recruiting
1,000 enrolled

Endometriosis, Leiomyoma, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡